|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Non-controlled/non-affiliated investments (amortized cost of $2,807,068 and $2,767,878 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Non-controlled | ||||||||||
| Total non-controlled/non-affiliated investments (amortized cost of $2,807,068 and $2,767,878 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Cash and cash equivalents (restricted cash of $75,391 and $61,386 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Derivative contracts, at fair value (net proceeds $) | ||||||||||
| Derivative assets, at fair value | ||||||||||
| Receivable for investments sold | ||||||||||
| Prefunded Investments | ||||||||||
| Interest receivable | ||||||||||
| Dividends receivable | ||||||||||
| Deferred financing costs | ||||||||||
| Deferred offering costs | ||||||||||
| Other assets | ||||||||||
| Total Assets | ||||||||||
| Liabilities and Equity | ||||||||||
| Liabilities | ||||||||||
| Revolving Credit Facilities | ||||||||||
| Debt Securitizations (net of debt issuance costs of $4,279 and $0 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Repurchase Obligations | ||||||||||
| Distributions payable | ||||||||||
| Payable for investments purchased | ||||||||||
| Interest payable | ||||||||||
| Derivative liabilities, at fair value | ||||||||||
| Management Fees payable | ||||||||||
| Due to affiliates | ||||||||||
| Preferred shareholders dividends payable | ||||||||||
| Board of Trustees' fees payable | ||||||||||
| Accrued expenses and other liabilities | ||||||||||
| Total Liabilities | ||||||||||
| Series A Preferred Shares, $0.001 par value; unlimited shares authorized; 500 shares issued and outstanding; liquidation preference of $3,000 per share | ||||||||||
| Components of Net Assets Applicable to Common Stock | ||||||||||
| Common Shares, $0.001 par value; unlimited shares authorized; 54,778,146 and 51,369,200 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid in capital | ||||||||||
| Distributable earnings | ||||||||||
| Total Net Assets Applicable to Common Shares | ||||||||||
| Total Liabilities, Series A Preferred Shares and Net Assets Applicable to Common Shares | ||||||||||
| Net Asset Value Per Common Share |
Loading...
